| Literature DB >> 28716717 |
Mark Mikkelsen1, Peter B Barker1, Pallab K Bhattacharyya2, Maiken K Brix3, Pieter F Buur4, Kim M Cecil5, Kimberly L Chan6, David Y-T Chen7, Alexander R Craven8, Koen Cuypers9, Michael Dacko10, Niall W Duncan11, Ulrike Dydak12, David A Edmondson12, Gabriele Ende13, Lars Ersland14, Fei Gao15, Ian Greenhouse16, Ashley D Harris17, Naying He18, Stefanie Heba19, Nigel Hoggard20, Tun-Wei Hsu21, Jacobus F A Jansen22, Alayar Kangarlu23, Thomas Lange10, R Marc Lebel24, Yan Li18, Chien-Yuan E Lin25, Jy-Kang Liou21, Jiing-Feng Lirng21, Feng Liu26, Ruoyun Ma12, Celine Maes27, Marta Moreno-Ortega28, Scott O Murray29, Sean Noah16, Ralph Noeske30, Michael D Noseworthy31, Georg Oeltzschner1, James J Prisciandaro32, Nicolaas A J Puts1, Timothy P L Roberts33, Markus Sack13, Napapon Sailasuta34, Muhammad G Saleh1, Michael-Paul Schallmo29, Nicholas Simard35, Stephan P Swinnen36, Martin Tegenthoff19, Peter Truong37, Guangbin Wang15, Iain D Wilkinson20, Hans-Jörg Wittsack38, Hongmin Xu18, Fuhua Yan18, Chencheng Zhang39, Vadim Zipunnikov40, Helge J Zöllner41, Richard A E Edden42.
Abstract
Magnetic resonance spectroscopy (MRS) is the only biomedical imaging method that can noninvasively detect endogenous signals from the neurotransmitter γ-aminobutyric acid (GABA) in the human brain. Its increasing popularity has been aided by improvements in scanner hardware and acquisition methodology, as well as by broader access to pulse sequences that can selectively detect GABA, in particular J-difference spectral editing sequences. Nevertheless, implementations of GABA-edited MRS remain diverse across research sites, making comparisons between studies challenging. This large-scale multi-vendor, multi-site study seeks to better understand the factors that impact measurement outcomes of GABA-edited MRS. An international consortium of 24 research sites was formed. Data from 272 healthy adults were acquired on scanners from the three major MRI vendors and analyzed using the Gannet processing pipeline. MRS data were acquired in the medial parietal lobe with standard GABA+ and macromolecule- (MM-) suppressed GABA editing. The coefficient of variation across the entire cohort was 12% for GABA+ measurements and 28% for MM-suppressed GABA measurements. A multilevel analysis revealed that most of the variance (72%) in the GABA+ data was accounted for by differences between participants within-site, while site-level differences accounted for comparatively more variance (20%) than vendor-level differences (8%). For MM-suppressed GABA data, the variance was distributed equally between site- (50%) and participant-level (50%) differences. The findings show that GABA+ measurements exhibit strong agreement when implemented with a standard protocol. There is, however, increased variability for MM-suppressed GABA measurements that is attributed in part to differences in site-to-site data acquisition. This study's protocol establishes a framework for future methodological standardization of GABA-edited MRS, while the results provide valuable benchmarks for the MRS community.Entities:
Keywords: Editing; GABA; MEGA-PRESS; MRS; Multi-site study
Mesh:
Substances:
Year: 2017 PMID: 28716717 PMCID: PMC5700835 DOI: 10.1016/j.neuroimage.2017.07.021
Source DB: PubMed Journal: Neuroimage ISSN: 1053-8119 Impact factor: 6.556